If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

Share Price is delayed by 15 minutes
Get Live Data
124.00    -0.50 (-0.40%)
Bid:
122.00
Ask:
126.00
Spread: 4.00 (3.279%)
Market Cap: £41.91m
ONWD Live PriceLast checked at - London Stock Exchange

Intraday Onward Opps Share Chart

Portfolio Update

10 Jan 2024 07:00

RNS Number : 1639Z
Onward Opportunities Limited
10 January 2024
 

 

10 January 2024

 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

 

Portfolio Update

 

Onward Opportunities Limited (AIM: ONWD), the investment company targeting opportunities in smaller companies within the UK, provides an update for the financial year ended 31 December 2023 ("FY23").

 

Company Update

 

· FY23 unaudited Net Asset Value (NAV) Total Return of +11.3% to 106.5p/share over the period from 30 March 2023 to 31 December 2023

 

· Encouraging first financial year ahead of target returns in difficult market conditions, delivering investment outperformance (NAV growth) relative to:

 

Indices - Outperformed UK AIM All Share by 16.6%; +11.3% Company NAV increase versus decline of 5.3% for UK AIM All Share

Peers - Top decile performance in AIC UK Smaller Companies sector since inception; and

The Company's target returns of >15% IRR stated at the time of IPO - The portfolio delivered an aggregated IRR of 22.6% and the invested portfolio as at year-end had generated an unrealised IRR of 40.2%

 

· In March 2023, the Company completed its IPO notwithstanding challenging market conditions. The Company successfully completed a further capital raise in September 2023, increasing the Company's capital base by 25% and welcoming a number of new shareholders to the Company.

 

Portfolio Update

 

· Significant early contributions from both the core stable and nursery holdings; top five contributors to unrealised return were Angling Direct, MPAC Group, EKF Diagnostics, Windward and Springfield Properties

 

· This early IRR performance is indicative of further upside within the existing portfolio, as well as the attractive pipeline of portfolio investments the manager is identifying in current markets over the medium to long term

 

· DX Group was the first takeover of an investee company, generating an IRR of 197%

 

· Portfolio has captured an income stream, that at FY24 dividend levels, is expected to offset the majority of the total expense ratio of the Company in the forthcoming year

 

· Intense period of investment activity capitalising on the value opportunity in UK smaller companies; the Company was over 90% invested by year-end. The top 10 holdings represent 60% of NAV

 

 

 

Laurence Hulse, Investment Director & Founder, said:

 

"The team is delighted to have delivered a NAV return of +11.3% net of launch costs in our first 9-months of operation, comparing favourably to the rest of the peer group and comparator indices. It was particularly pleasing to quickly earn back the IPO launch costs for shareholders who supported us.

"Onward Opportunities is all about truly active management; we are building a portfolio of specialist investment ideas for existing and prospective shareholders to access. Company resource is deployed analysing high conviction opportunities and then engaged to help unlock the value identified. We look forward to the portfolio developing further in the coming months. Onwards."

 

For further information, please contact:

 

 

Onward Opportunities Limited

Andrew Henton, Chairman

 

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Investment Director

 

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

 

 

Apex Administration (Guernsey) Limited (Company Secretary)

Martin Baxter / Harry Rouillard

 

Tel: +44 (0) 203 5303 150

ool@maitlandgroup.com

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes/Camilla Hume

 

Tel: +44 (0)20 7397 8900

Dowgate Capital Limited (Joint Broker)

Russell Cooke / Nicholas Chambers

 

Tel: +44 (0)12 9351 7744

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUDGGDBSSGDGSC
Date   Source Headline
2nd Jan 20255:50 pmRNSNet Asset Value(s)
6th Dec 20247:00 amRNSAdditional Subscription and Total Voting Rights
4th Dec 20247:00 amRNSIssue of Equity
2nd Dec 20245:38 pmRNSNet Asset Value(s)
1st Nov 20244:42 pmRNSNet Asset Value(s)
30th Oct 20244:40 pmRNSHolding(s) in Company
24th Oct 202412:00 pmRNSIssue of Equity
11th Oct 20247:00 amRNSPublication of Q3 2024 Factsheet
3rd Oct 20243:44 pmRNSHolding(s) in Company
2nd Oct 20244:34 pmRNSNet Asset Value(s)
26th Sep 20243:27 pmRNSAdditional Subscription and Total Voting Rights
26th Sep 20247:00 amRNSIssue of Equity
6th Sep 20247:00 amRNSHalf-year Report
3rd Sep 20244:21 pmRNSNet Asset Value
2nd Aug 20242:16 pmRNSNet Asset Value(s)
19th Jul 20242:31 pmRNSAcquisition of Interest in The Mission Group plc
11th Jul 20247:00 amRNSHalf-Year Update
4th Jul 20247:00 amRNSNet Asset Value(s)
3rd Jul 20247:00 amRNSIssue of Equity
11th Jun 20249:06 amRNSResult of AGM
4th Jun 20247:00 amRNSNet Asset Value(s)
8th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20247:00 amRNSNet Asset Value(s)
26th Apr 20247:00 amRNSIssue of Equity/Director/PDMR Shareholding
11th Apr 20247:00 amRNSAnnual Results
3rd Apr 20247:00 amRNSNet Asset Value(s)
28th Mar 20244:51 pmRNSHolding(s) in Company
26th Mar 20247:00 amRNSIssue of Equity
5th Mar 20243:21 pmRNSNet Asset Value(s)
22nd Feb 20242:20 pmRNSDirector/PDMR Shareholding
2nd Feb 20247:00 amRNSNet Asset Value(s)
18th Jan 202410:44 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSQuarterly Factsheet – Q4 2023
10th Jan 20247:00 amRNSPortfolio Update
4th Jan 20247:00 amRNSNet Asset Value(s)
18th Dec 202311:26 amRNSHolding(s) in Company
4th Dec 20233:19 pmRNSNet Asset Value(s)
3rd Nov 20233:14 pmRNSNet Asset Value(s)
31st Oct 202312:00 pmRNSTVR & Change of Nominated Adviser and Joint Broker
24th Oct 20237:00 amRNSQuarterly Factsheet - Q3 2023
11th Oct 20235:39 pmRNSHolding(s) in Company
9th Oct 20235:06 pmRNSHolding(s) in Company
5th Oct 20232:54 pmRNSNet Asset Value(s)
4th Oct 20237:00 amRNSIssue of Equity
4th Sep 20237:00 amRNSNet Asset Value(s)
4th Sep 20237:00 amRNSHalf-year Report
3rd Aug 20232:08 pmRNSNet Asset Value(s)
14th Jul 20237:00 amRNSQuarterly Factsheet – Q2 2023
5th Jul 20232:21 pmRNSNet Asset Value(s)
5th Jun 20235:36 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.